GVHD severity, donor-recipient blood type impact thromboembolic event risk
13 Jun 2021
In patients who develop chronic graft-versus-host disease (cGVHD) after haematopoietic cell transplantation (HCT), the risk of thromboembolic events (TEE) seems to be affected by disease severity and donor-recipient ABO blood group, a recent study has found.
Antibody cocktail cuts hospitalization, death in COVID-19
12 Jun 2021
The REGN-COV2 monoclonal antibody cocktail comprising casirivimab and imdevimab significantly reduces the risk of hospitalization and all-cause death by 71 percent compared with placebo in nonhospitalized patients with COVID-19, according to a large phase III study presented at the ATS 2021 Meeting.
Indications/Uses : Symptoms related to venolymphatic insufficiency (heavy legs, pain, restless legs syndrome at bedtime). Functional symptoms related to acute hemorrhoidal attack.
Indications/Uses : For body resistance & stress release. Stress relief & health benefits, optimize energy release for improved work performance & boost immune system against various illnesses & diseases.
Indications/Uses : Adjunct to diet & exercise to improve glycaemic control in patients w/ type 2 DM as monotherapy or combination therapy w/ metformin, sulphonylurea + metformin or insulin w/ or w/o metformin.
Manage Account
Change Password
Sign Out
